Stuart A. Montgomery, MD, FRCPsych
- 18Articles
- 66.6KReads1
- 1998–2016Active
- 78Collaborators
- 284Citations2
About
Stuart A. Montgomery, MD, FRCPsych, has published extensively on major depressive disorder, anxiety, and suicide, with a focus on pharmacological treatments and clinical outcomes. His work includes studies on adjunctive therapies such as cariprazine and extended-release quetiapine, as well as investigations into late-life depression and preventive treatments for recurrent depression and generalized anxiety disorder. Montgomery’s research spans randomized, double-blind, placebo-controlled trials assessing efficacy and safety of various antidepressants and anxiolytics. He has frequently collaborated with co-authors including Hans-Jürgen Möller, Siegfried Kasper, and Alan F. Schatzberg.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
